CNBX Pharmaceuticals Inc (CNBX)

[jim992]

I Requested Results of OTCM's Scrutiny of CNBX:

CNBX's credibility was severely damaged by an announcement made by OTC Markets February 21st, 2017 regarding the fact they were going to "scrutinize" CNBX for their recent stock price surge.

Now that CNBX has dropped five dollars in value, nothing has been reported by OTCM regarding their findings.

If you are going to announce scrutiny before announcing findings, you should have to also share the findings of the scrutiny, whether positive or negative.

Use the following email link if you would also like to ask OTCM to share their findings: http://www.otcmarkets.com/contactUs

Below is what I submitted to OTCM 4-9-17:

As noted in numerous articles below, on February 21st, 2017, OTC Markets announced that they were looking into Cannabics Pharmaceuticals (CNBX) due to their recent stock price surge.

The announcement of OTCM's "scrutiny" had an immediate cooling effect on the stock and it has not recovered since.

While it could possibly be said that the statement did not cause the stock price to drop, it has been almost 60 days since the announcement was made.

Can you please advise the current findings of the heightened scrutiny that OTCM announced?

If you are going to make announcements regarding such heightened scrutiny, proof of said scrutiny and the results of it should also be announced.

Those of us who had years worth of CNBX investments cut would like to know what the heightened scrutiny has found so as to act accordingly. (There would be no reason to announce the scrutiny ahead of findings if the positive or negative findings were not going to be shared publicly).

Thank you for your time and concern. James Patton

Following are just a few of the links to said announcement appearing in the press:

https://www.newcannabisventures.com/cannabics-pharmaceuticals-triggers-regulatory-scrutiny-after-parabolic-spike/

http://finance.yahoo.com/news/cannabics-pharmaceuticals-inc-provides-shareholders-140000767.html?soc_src=social-sh&soc_trk=tw

https://www.newcannabisventures.com/cannabics-pharmaceuticals-triggers-regulatory-scrutiny-after-parabolic-spike/

https://seekingalpha.com/instablog/6880-alan-brochstein-cfa/4963347-capitalize-cannabis-report-02-25-17